Evidence map›Paper›PMID 18220662›Full record

ReviewCurrent diabetes reviews2007

"Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Joseph T Brozinick, Bradley A Berkemeier, Jeffrey S Elmendorf

Open access · greenAbstract readReview
In one paragraph

Review in Current diabetes reviews, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Focal Adhesion Kinase Orchestrates GLUT4 Translocation and Glucose Uptake via Cytoskeletal Turnover in Primary Adipocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joseph T BrozinickEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. brozinick_joseph_t@lilly.com
Bradley A Berkemeier
Jeffrey S Elmendorf
Eli Lilly (United States) · US

Funding

CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTSR01AT001846 · NCCIH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ELMENDORF, JEFFREY S · 2004 to 2008
$1.4M
NCCIH NIH HHS R01 AT001846
6 · The paper itself

Abstract

The dissection of mechanisms that regulate glucose transport by insulin has revealed an intricate network of signaling molecules scattered from the insulin receptor to the intracellular glucose transporter GLUT4. It is also appreciated that some insulin receptor signals jaunt in different directions to regulate events essential for the efficient redistribution of GLUT4 to the plasma membrane. Moreover key assists in the process appear to be arranged by membrane lipids and cytoskeletal proteins. Following current considerations of insulin signals regulating GLUT4, this review will focus on in vitro and in vivo evidence that supports an essential role for phosphoinositides and actin filaments in the control of glucose transport. The discussion will visit recent cell culture, whole animal, and human data highlighting membrane and cytoskeletal aspects of insulin resistance.

Indexed as

ActinsAnimalsCell MembraneCytoskeletonGlucose Transporter Type 4HumansInsulinInsulin ResistanceModels, BiologicalPhosphatidylinositolsProtein TransportSignal TransductionActinsGlucose Transporter Type 4InsulinPhosphatidylinositols

Identifiers

PMID18220662
PMCPMC2396947
OpenAlexW2150928765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.